Nomination Committe for IDL appointed | IDL Biotech
IDL Biotech



Latest News

February 2019

Nomination Committe for IDL appointed

IDL Biotechs extra ordinary general meeting held on the 25th October 2018 decided to establish a nomination committee.

The two largest shareholders in terms of votes who wish to participate in the nomination committee were entitled to appoint one member each. The shareholders Leif Pihlqvist with companies and AB Grenspecialisten has appointed Jerker Swanstein and Jens Ismunden.


For more information, read the pressrelease here (in swedish)

AroCell AB (publ) riktar offentligt uppköpserbjudande till aktieägarna i IDL Biotech AB (publ)

IDL Biotech AB uppmärksammar härmed att AroCell AB (publ) idag har lämnat ett uppköpserbjudande till aktieägarna i IDL att överlåta samtliga aktier till AroCell i utbyte mot 0,63 AroCell-aktier för varje aktie i IDL.

IDL Biotech is making progress in Africa

IDL Biotech has now received its first order from the company's distributor in Uganda, Medilink Lab & Surgical Ltd. The order refers to TUBEX® TF, IDL Biotech's rapid test for typhoid fever. Uganda will thus be the third country in Africa to which the company delivers TUBEX® TF.

IDL Biotech

Skip this intro